Also trades as: ARGX.BR (BRU) · $vol 83M · 0QW0.IL (IOB) · $vol 25M · 0QW0.L (LSE) · $vol 25M · ARGNF (OTC) · $vol 0M

$919.21

-16.79 (-1.79%)

Weekly Expected Move ±2.9%

$865 $892 $919 $946 $973

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $57.2B mcap · 62M float · 0.494% daily turnover · Short 53% of daily vol

Revenue

$4.2B +90.1% ▲

5Y CAGR: +151.7%

Gross Profit

$3.7B +89.1% ▲

5Y CAGR: +146.0%

Operating Income

$972M +4590.9% ▲

Net Income

$1.3B +55.6% ▲

EPS (Diluted)

$19.63 +53.6% ▲

EBITDA

$972M +824.6% ▲

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$497M	$411M	$1.2B	$2.2B	$4.2B
YoY Growth	+1105.7%	-17.4%	+198.6%	+78.6%	+90.1%
Cost of Revenue	$0	$29M	$118M	$227M	$452M
Gross Profit	$497M	$381M	$1.1B	$2.0B	$3.7B
Gross Margin	100.0%	92.8%	90.4%	89.6%	89.1%
R&D Expenses	$581M	$663M	$859M	$983M	$1.4B
SG&A Expenses	$306M	$470M	$710M	$1.1B	$1.4B
Operating Expenses	$846M	$1.1B	$1.5B	$2.0B	$2.7B
Operating Income	-$349M	-$720M	-$425M	-$22M	$972M
Operating Margin	-70.1%	-175.4%	-34.7%	-1.0%	23.4%
Interest Expense	$1M	$2M	$904K	$2M	$4M
Income Before Tax	-$400M	-$729M	-$304M	$85M	$1.3B
Tax Expense	$9M	-$20M	-$9M	-$748M	-$13M
Net Income	-$408M	-$710M	-$295M	$833M	$1.3B
Net Margin	-82.0%	-172.8%	-24.1%	38.0%	31.1%
EPS (Diluted)	$-7.99	$-13.05	$-5.16	$12.78	$19.63
EBITDA	-$393M	-$623M	-$192M	$105M	$972M
Shares Outstanding	51M	54M	57M	65M	66M

Line Item	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$401M	$902M	$573M	$1.3B	$791M	$948M	$3.2B	$2.8B
Cost of Revenue	$43M	-$438M	$59M	$665M	$81M	$111M	$340M	$279M
Gross Profit	$358M	$1.3B	$514M	$681M	$710M	$837M	$2.9B	$2.5B
Gross Margin	89.2%	142.1%	89.7%	50.6%	89.8%	88.3%	89.4%	90.1%
R&D Expenses	$225M	$447M	$236M	$297M	$309M	$328M	$443M	$486M
SG&A Expenses	$236M	$492M	$278M	$564M	$276M	$601M	$355M	$773M
Operating Expenses	$451M	$495M	$500M	$563M	$571M	$636M	$2.0B	$1.7B
Operating Income	-$93M	-$139M	$14M	$117M	$139M	$201M	$851M	$847M
Operating Margin	-23.3%	-15.4%	2.5%	8.7%	17.6%	21.2%	26.5%	30.1%
Interest Expense	$512K	$572K	$676K	$704K	$1M	$1M	$1M	$2M
Income Before Tax	-$74M	-$89M	$88M	$175M	$202M	$287M	$992M	$959M
Tax Expense	-$13M	-$57M	-$3M	-$688M	$33M	$42M	-$55M	$119M
Net Income	-$62M	-$33M	$91M	$866M	$169M	$245M	$1.0B	$839M
Net Margin	-15.4%	-3.6%	15.9%	64.3%	21.4%	25.9%	32.7%	29.8%
EPS (Diluted)	$-1.04	$-0.55	$1.39	$12.20	$2.58	$6.37	$13.22	$13.02
EBITDA	-$74M	-$21M	$89M	$127M	$203M	$514M	$673M	$864M
Shares Outstanding	59M	59M	66M	71M	66M	66M	66M	64M

ARGX NASDAQ